Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT06550518
Eligibility Criteria:
Inclusion Criteria:
* Adults (age ≥18 years)
* Histologically or cytologically SCLC diagnosis
* Treated with epirubicin-paclitaxel doublet between January 2010 and December 2020
Exclusion Criteria:
* Opposition to participate registered
* Patients under legal protection
* Patients afflicted by another subtype of lung carcinomas
* SCLC not treated with the epirubicin-paclitaxel doublet
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06550518
Study Brief:
Protocol Section:
NCT06550518